Insider · CIK 0002111813
Anand Kiran Parikh
Files at FTH (Sensei Biotherapeutics, Inc.). First filing Jun 24, 2026, latest Jun 24, 2026.
In brief
Anand Kiran Parikh files SEC Form 4 as COO, director, CEO and president at FTH (Sensei Biotherapeutics, Inc.). Since Jun 24, 2026, Anand Kiran Parikh has reported 1 open-market buy worth $55k and 0 open-market sells worth $0, the latest filed on Jun 24, 2026.
A track record needs three past buys with six months of prices behind them; Anand Kiran Parikh has 0, so none is measured yet.
The newest scored trade: bought $55k of FTH on Jun 22, 2026, filed Jun 24, 2026, scored 43 (moderate). In the last 12 months: 1 buy worth $55k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FTH: Sensei Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Sensei Biotherapeutics, Inc. | $55k 2,806 shares | +0% | +241% from low-34% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Performance-Based Stock Option (right to buy)derivative | +398,018 | $0.00 | $0 | 398,018 | Jul 23, 2026 |
| Jun 22, 2026 | FTH Sensei Biotherapeutics, Inc. | POpen-market purchase Common Stock | +2,806 | $19.76 | $55k | 764,234 | Jun 24, 2026 |
| Jun 22, 2026 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Common Stock | +45,252 | $1.16 | $52k | 809,486 | Jun 24, 2026 |
| Jun 22, 2026 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Common Stock | +8,213 | $1.16 | $9,527 | 817,699 | Jun 24, 2026 |
| Jun 22, 2026 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative | -45,252 | $0.00 | $0 | 91,632 | Jun 24, 2026 |
| Jun 22, 2026 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative | -8,213 | $0.00 | $0 | 4,107 | Jun 24, 2026 |
| Jun 15, 2026 | FTH Sensei Biotherapeutics, Inc. | CConversion Common Stock | +761,428 | - | - | 761,428 | Jun 16, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Series B Preferred Stockderivative | +761 | - | - | 761,428 | Jun 16, 2026 |
| Jun 15, 2026 | FTH Sensei Biotherapeutics, Inc. | CConversion Series B Preferred Stockderivative | -761 | - | - | 0 | Jun 16, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +12,320 | - | - | 12,320 | Jun 16, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +136,884 | - | - | 136,884 | Jun 16, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Series B Preferred Stockderivative | +809,822 | - | - | 809,822 | Feb 19, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +92,533 | - | - | 92,533 | Feb 19, 2026 |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +56,673 | - | - | 56,673 | Feb 19, 2026 |
| Feb 19, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +1,239,305 | $0.00 | $0 | 1,239,305 | Feb 19, 2026 |
Questions about Anand Kiran Parikh
Answered from the filings on this page, as of the latest one.
Is Anand Kiran Parikh buying or selling?
In the last 12 months Anand Kiran Parikh reported 1 open-market buy worth $55k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $55k of FTH on Jun 22, 2026. Grants, option exercises and tax withholding are not counted.
How did Anand Kiran Parikh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anand Kiran Parikh has 0.
Where does Anand Kiran Parikh file Form 4?
Anand Kiran Parikh has filed Form 4 at FTH (Sensei Biotherapeutics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.